Find Edurant / Truvada manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Edurant / truvada, Emtricitabine / rilpivirine /tenofovir disoproxil, Emtricitabine mixture with rilpivirine hydrochloride and tenofovir disoproxil fumarate, 847446-10-0
Molecular Formula
C53H63ClFN14O17PS
Molecular Weight
1285.6  g/mol
InChI Key
NEZNLHNPLRCSOG-FNZDRVHOSA-N

Edurant / Truvada
1 2D Structure

Edurant / Truvada

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one;[[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-(propan-2-yloxycarbonyloxymethoxy)phosphoryl]oxymethyl propan-2-yl carbonate;(E)-but-2-enedioic acid;4-[[4-[4-[(E)-2-cyanoethenyl]-2,6-dimethylanilino]pyrimidin-2-yl]amino]benzonitrile;hydrochloride
2.1.2 InChI
InChI=1S/C22H18N6.C19H30N5O10P.C8H10FN3O3S.C4H4O4.ClH/c1-15-12-18(4-3-10-23)13-16(2)21(15)27-20-9-11-25-22(28-20)26-19-7-5-17(14-24)6-8-19;1-12(2)33-18(25)28-9-31-35(27,32-10-29-19(26)34-13(3)4)11-30-14(5)6-24-8-23-15-16(20)21-7-22-17(15)24;9-4-1-12(8(14)11-7(4)10)5-3-16-6(2-13)15-5;5-3(6)1-2-4(7)8;/h3-9,11-13H,1-2H3,(H2,25,26,27,28);7-8,12-14H,6,9-11H2,1-5H3,(H2,20,21,22);1,5-6,13H,2-3H2,(H2,10,11,14);1-2H,(H,5,6)(H,7,8);1H/b4-3+;;;2-1+;/t;14-;5-,6+;;/m.10../s1
2.1.3 InChI Key
NEZNLHNPLRCSOG-FNZDRVHOSA-N
2.1.4 Canonical SMILES
CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)C=CC#N.CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C.C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F.C(=CC(=O)O)C(=O)O.Cl
2.1.5 Isomeric SMILES
CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)/C=C/C#N.C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C.C1[C@H](O[C@H](S1)CO)N2C=C(C(=NC2=O)N)F.C(=C/C(=O)O)\C(=O)O.Cl
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. Edurant / Truvada

2. Emtricitabine / Rilpivirine /tenofovir Disoproxil

3. Emtricitabine Mixture With Rilpivirine Hydrochloride And Tenofovir Disoproxil Fumarate

4. 847446-10-0

2.3 Create Date
2012-03-21
3 Chemical and Physical Properties
Molecular Weight 1285.6 g/mol
Molecular Formula C53H63ClFN14O17PS
Hydrogen Bond Donor Count8
Hydrogen Bond Acceptor Count29
Rotatable Bond Count26
Exact Mass1284.3626506 g/mol
Monoisotopic Mass1284.3626506 g/mol
Topological Polar Surface Area471 Ų
Heavy Atom Count88
Formal Charge0
Complexity1800
Isotope Atom Count0
Defined Atom Stereocenter Count3
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count2
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count5
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameComplera
PubMed HealthEmtricitabine/Rilpivirine/Tenofovir (By mouth)
Drug ClassesAntiretroviral Agent
Drug LabelCOMPLERA is a fixed-dose combination tablet containing emtricitabine, rilpivirine hydrochloride, and tenofovir DF. EMTRIVA is the brand name for emtricitabine, a synthetic nucleoside analog of cytidine. EDURANT is the brand name for rilpivirine, a no...
Active Ingredienttenofovir disoproxil fumarate; rilpivirine hydrochloride; Emtricitabine
Dosage FormTablet
RouteOral
Strength300mg; 200mg; eq 25mg base
Market StatusPrescription
CompanyGilead Sciences

2 of 2  
Drug NameComplera
PubMed HealthEmtricitabine/Rilpivirine/Tenofovir (By mouth)
Drug ClassesAntiretroviral Agent
Drug LabelCOMPLERA is a fixed-dose combination tablet containing emtricitabine, rilpivirine hydrochloride, and tenofovir DF. EMTRIVA is the brand name for emtricitabine, a synthetic nucleoside analog of cytidine. EDURANT is the brand name for rilpivirine, a no...
Active Ingredienttenofovir disoproxil fumarate; rilpivirine hydrochloride; Emtricitabine
Dosage FormTablet
RouteOral
Strength300mg; 200mg; eq 25mg base
Market StatusPrescription
CompanyGilead Sciences

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty